Clinical Trial Update: New Version Pulmicort Turbuhaler USA Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a new version of Pulmicort Turbuhaler for asthma in US adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort Turbuhaler (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED